Development of Breast Cancer Spheroids to Evaluate Cytotoxic Response to an Anticancer Peptide

• Egile Nagusiak: Marco Cavaco (Egilea), Patrícia Fraga (Egilea), Javier Valle (Egilea), David Andreu (Egilea), Miguel A. R. B. Castanho (Egilea), Vera Neves (Egilea)
• Formatua: Liburua
• Argitaratua: MDPI AG, 2021-11-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Breast cancer (BC) is the most commonly diagnosed cancer in women and one of the most common causes of cancer-related deaths. Despite intense research efforts, BC treatment still remains challenging. Improved drug development strategies are needed for impactful benefit to patients. Current preclinic...